Mitral Valve-in-Valve Versus Repeat Surgical Mitral Valve Replacement in Patients With Failed Mitral Bioprostheses.

J Soc Cardiovasc Angiogr Interv · 2023 · PMC11307612 · PMID 39132537

Europe PMC DOI

hedged sentence

0.0690

closest p · 1.4× alpha

0.0690

boldest claim

The sentences

did not reach statistical significanceP = .069so close (0.05 < p ≤ 0.1)

The short-term mortality (<1 year) was numerically lower in the MViV replacement group and did not reach statistical significance (5% in the MViV replacement group vs 10% in the redo-SMVR group; OR, 0.45; 95% CI, 0.18-1.13; P = .069; I 2 = 0%).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.